This HTML5 document contains 84 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q64795894
rdf:type
wikibase:Item
schema:description
клінічне випробування ensayu clínicu clinical trial klinisch onderzoek
rdfs:label
Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix
skos:prefLabel
Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix
schema:name
Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix
p:P1476
wds:Q64795894-0F364339-35D8-4724-A40C-4CEC29E707E9
wdt:P1476
A Randomized Phase III Trial of Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab Versus Platinum Chemotherapy Plus Paclitaxel and Bevacizumab in Metastatic (Stage IVB), Persistent, or Recurrent Carcinoma of the Cervix
p:P582
wds:Q64795894-1F2A539A-30A6-4007-9D79-22CF8662AA74
wdt:P582
2023-03-01T00:00:00Z
p:P31
wds:Q64795894-45B8304B-EE00-4F54-A8FB-3582FBCA244B
wdt:P31
wd:Q30612
p:P580
wds:Q64795894-E9E0F13C-8463-441A-BE0A-371EC0EBFF34
wdt:P580
2018-09-25T00:00:00Z
p:P17
wds:Q64795894-E60BB2CB-E178-4A2D-B9CD-26C3ECFF5AE9 wds:Q64795894-657B5EF0-12BF-4ADA-A06E-65BB76CB6750
wdt:P17
wd:Q17 wd:Q29
p:P6153
wds:Q64795894-0EC554E5-BDF5-4B12-A995-4A0BC27C318F wds:Q64795894-192BD3EC-4C32-4EE3-86AB-52287F9FE828 wds:Q64795894-0F9FE0D1-4FA1-4BCF-A5F6-27FDCBE71FE0 wds:Q64795894-01C66AA4-EF43-47E9-8DAD-73F0EC9BB34C wds:Q64795894-F5ABE8EF-9478-422E-9834-6B6F0D7D427E wds:Q64795894-FE9987D8-B412-4843-9624-71F3E7426799 wds:Q64795894-FC8FD48F-DEBA-4C70-BDB8-6591757D63C7 wds:Q64795894-9B6DE22F-BC20-44CD-BF8D-A41870F00AA1 wds:Q64795894-B37D31A7-7E04-4B75-A1CA-8760F714D49D wds:Q64795894-AF8F865B-42B0-402B-B798-E3DC93D3AC18 wds:Q64795894-F2F48109-E47A-4695-9C85-1B999B8B2DB2 wds:Q64795894-89942AB1-CA0B-4D7F-8A94-341D5BBB20F5 wds:Q64795894-817DFE08-127F-4DE4-ADB5-AD7594D5A33A wds:Q64795894-9AA66AE0-96B0-4B99-BE51-ABE0710AFA00 wds:Q64795894-CEA4A59F-DA88-46DB-9F37-8E236795CF74 wds:Q64795894-9154EF0C-7F4E-4F7C-AA72-787922D2B2EA wds:Q64795894-CD42E9AF-C0B7-4956-A78A-1D2A12E45FDC wds:Q64795894-69409733-1162-43F1-825F-7436B12B8E87 wds:Q64795894-7A224303-A89A-4139-BCD7-010FDE78F32C wds:Q64795894-6E73E12B-AC2E-480D-B464-2258A66E57C4 wds:Q64795894-64979A9B-3944-4834-B3C5-51520540704E wds:Q64795894-2A5E3113-18C2-4A9A-9B99-540DF7EEB5AC
wdt:P6153
wd:Q11663219 wd:Q1501084 wd:Q2945675 wd:Q3826080 wd:Q30279623 wd:Q815432 wd:Q5902953 wd:Q30254321 wd:Q5902966 wd:Q7855557 wd:Q11502859 wd:Q5902531 wd:Q218506 wd:Q219564 wd:Q55599819 wd:Q185246 wd:Q56403399 wd:Q30282164 wd:Q486156 wd:Q7402537 wd:Q4586373 wd:Q266227
p:P4844
wds:Q64795894-6C4B94A4-4150-4A04-B576-ACA75641D1C7 wds:Q64795894-0A4C8865-DED3-4BEE-B7DB-216AC359CE82 wds:Q64795894-F400FA8F-9298-40FB-B174-9FE100BBEAC1
wdt:P4844
wd:Q413299 wd:Q423762 wd:Q412415
p:P2899
wds:Q64795894-FB1E991E-9051-49F6-B781-7D8B69133049
wdt:P2899
18
p:P1050
wds:Q64795894-511BAFC4-9366-443E-BA4B-4F864E8A4C59
wdt:P1050
wd:Q33525
p:P1132
wds:Q64795894-C867A06D-81F9-4815-87F1-6C5AAACF36E4
wdt:P1132
404
p:P767
wds:Q64795894-BAD1B8CD-6BBC-407D-8524-7E9C2A941838
wdt:P767
wd:Q212646
p:P8363
wds:Q64795894-3F022924-1D58-489D-A269-42BBF5E3388F
wdt:P8363
wd:Q78089383
p:P3098
wds:Q64795894-A5BD2B71-58EB-4C8E-875B-8A1F22D23FC4
wdt:P3098
NCT03556839
p:P6099
wds:Q64795894-3AE946EA-E46C-4FD0-814E-05041D0F32F8
wdt:P6099
wd:Q42824827